ApprovalTrail

Drug · DIN 02510995

TISSUEBLUE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since September 30, 2021; first marketed September 30, 2021.
Drug Identification Number (DIN)
02510995
Company (DIN owner)
Dutch Ophthalmic Research Center International BvZuidland, Zuid-Holland, Netherlands
Schedule
Prescription
Dosage form
Solution
Route
Intravitreal
Therapeutic class (ATC)
Surgical aids S01K
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
BRILLIANT BLUE G0.25 MGML

Notices of Compliance

Health Canada approvals that name this DIN.